Clinical Trials Logo

Filter by:
NCT ID: NCT05557721 Enrolling by invitation - Clinical trials for Primary Open Angle Glaucoma

Uddevalla Skövde Transscleral Micropulse Study

USTMS
Start date: October 6, 2023
Phase:
Study type: Observational

Micro pulse transscleral laser treatment (MP-TLT) is a relatively new method to reduce the intraocular pressure (IOP) in glaucoma. New recommendations regarding the treatment protocol has recently been developed and was published 2022. The overall objective is to evaluate the efficacy and safety of the proposed treatment method in an independent study. In addition, the outcome of MP-TLT in patients with pseudoexfoliation glaucoma, which is relatively common in the Nordic countries, and primary open angle glaucoma will be studied separately. The IOP change over the course of one year will be monitored, as well as success rate and survival. Further, patient-reported discomfort from the treatment and the occurrence of any adverse events or complications will be studied.

NCT ID: NCT05557617 Active, not recruiting - Alzheimer Disease Clinical Trials

Periodontitis and Periodontal Bacteria in Dementia

Start date: October 30, 2020
Phase:
Study type: Observational

The study is designed to inquire whether the presence of periodontitis and different periodontopathogenic bacterial strains are associated with dementia diagnosis and with the degree of cognitive impairment in participants evaluated at a Memory clinic (Minnesmottagning). Specifically, by analyzing cerebrospinal fluid, the investigators intend to clarify whether the alleged mechanisms for Porphyromonas gingivalis in the aetiology of Alzheimer disease (AD) are supported in a Swedish population and whether they are specific for Porphyromonas gingivalis (as compared to other periodontopathogenic bacteria) and Alzheimer type dementia (as compared to other etiological dementia types), respectively.

NCT ID: NCT05556486 Recruiting - Glioma, Malignant Clinical Trials

Mapping of Tumor Stem Cells in the Resection Marigin During Extirpation of Highly Malignant Gliomas Using GlioStem

CeNo2
Start date: May 5, 2022
Phase:
Study type: Observational

The study investigates the occurance of GlioStem positive tumor stem cells in the rescection marigins of hig grade human gliomas

NCT ID: NCT05555082 Completed - Quality of Life Clinical Trials

Can Massage During One Year Improve Health in Health-care Providers Working in Hospital

Start date: November 20, 2022
Phase: N/A
Study type: Interventional

The overall aim of this pilot study is to investigate the effect, "feasibility" and experiences of regular massage over 12 months on the mental and physical health of healthcare professionals, as well as the frequency of layoffs, sick leave and reported patient safety risk cases, as well as health economics

NCT ID: NCT05554809 Enrolling by invitation - Muscle Tightness Clinical Trials

Unilateral Stretch Crossover Effect RCT

Start date: September 15, 2022
Phase: N/A
Study type: Interventional

The crossover-effect within resistance- and strength training is more or less confirmed with multiple studies showing similar results. The studies shows an increase in muscle strength within the contralateral extremity being exercised. Regarding muscle length or mobility (flexibility) the crossover-effect have not been studied. For a person to gain an increase in muscle strength mobility training in the form of stretching and flexibility training of our skeletal muscle is a common exercise. However, the evidence are scare and there are only a few studies comparing the effect of prolonged static stretching (> 90 sec) and dynamic flexibility training as to which of these methods has the best length-enhancing effect over time. The purpose of this study is to compare the crossover-effect of eight weeks of oneleg dynamic flexibility training versus oneleg prolonged static stretching versus a nonstretching controlgroup on mobility in the hamstring muscles in adults with reduced mobility of the hamstring muscle. The aim is also to compare the sustained effect of flexibility training between the two groups, eight weeks after completion of the intervention.

NCT ID: NCT05554107 Recruiting - Clinical trials for POTS - Postural Orthostatic Tachycardia Syndrome

The Effect of Physical Activity on Postural Orthostatic Tachycardia Syndrome

POTS
Start date: November 2, 2022
Phase: N/A
Study type: Interventional

Postural orthostatic tachycardia syndrome (POTS) is a disorder of unknown origin characterized by orthostatic intolerance and increased heart rate (HR) of ≥ 30 beats/minute during orthostasis in the absence of orthostatic hypotension. In addition to the orthostatic intolerance and tachycardia, patients with POTS experience several debilitating symptoms including light-headedness, nausea, blurred vision, fatigue, mental confusion ("brain-fog"), chest pain and gastrointestinal problems. Several potential underlying mechanisms have been suggested for POTS including autonomic denervation, hypovolemia, hyperadrenergic stimulation and autoantibodies against adrenergic receptors. However, none of these proposed mechanisms has yet led to an effective treatment. Physical activity is recommended as a complimentary treatment in POTS in international guidelines. However, less is known regarding how physical activity could successfully be implemented in clinical practice in patients with POTS. Thus, in the current study, we aim to assess the effect of a 16-week specialized physical activity program in POTS.

NCT ID: NCT05553808 Completed - Neoplasms Clinical Trials

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1

Start date: January 24, 2019
Phase: Phase 2
Study type: Interventional

This study is a sub-study of the master protocol 205801 (NCT03739710). This sub study has assessed the clinical activity of novel regimen (Feladilimab plus Docetaxel) with SOC (Docetaxel) in participants with NSCLC.

NCT ID: NCT05552326 Recruiting - Clinical trials for Severe Hypertriglyceridemia

A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia

Start date: August 31, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of olezarsen as compared to placebo on the percent change in fasting triglycerides (TG) from baseline.

NCT ID: NCT05552222 Recruiting - Multiple Myeloma Clinical Trials

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

MajesTEC-7
Start date: October 25, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy of teclistamab in combination with daratumumab and lenalidomide (Tec-DR) and talquetamab in combination with daratumumab and lenalidomide (Tal-DR) versus daratumumab, lenalidomide, dexamethasone (DRd).

NCT ID: NCT05551351 Recruiting - Coronary Stenosis Clinical Trials

CT in Calcified Coronary Arteries With Photon Counting Detector

CCT-PCD-1
Start date: February 16, 2023
Phase:
Study type: Observational

Coronary CT angiography is challenging in patients with more than mildly calcified coronary vessels, because of calcium artefacts that prevents evaluation of the lumen. The purpose of the CCT-PCD-1-study is to evaluate the diagnostic accuracy and image quality in coronary CT angiography using a commercially available CT system equipped with a photon counting detector technology. Patients referred for cardiac CT and conventional coronary angiography as part of routine preoperative evaluation before Transcatheter Aortic Valve Implantation (TAVI) will be asked for inclusion in the study. This group of patients has generally a coronary artery calcium burden and perform cardiac CT and coronary angiography as part of routine care. The diagnostic accuracy concerning significant coronary artery stenosis on the preoperative CT will be evaluated with the conventional coronary angiography as reference. Also, CT examination image quality will be evaluated.